[Intracavernosa injections of drugs in erection disorders. Their clinical value apropos of 100 cases].
Several centers of interest have been stimulated by the true progress represented by the use of intracavernous injections (ICI) for disorders of erection. First, we have become conscious of our uncertainties concerning the physiology of erection. Second, they serve to orientate the etiologic diagnosis and prognosis when positive responses are obtained in cases of impotence. Third, they are of therapeutic interest as auto-injections in impotence with, however, the risk of secondary cavernous fibrosis. Lastly, they represent a new treatment for priapism. However, these ICI procedures are still in the experimental stage, and should be used with some caution because of their potential morbidity and unknown long-term effects.
Service d'urologie CHU Lille.
P
P
Bondil
J M
JM
Rigot
J L
JL
Nguyen Qui
E
E
Mazeman
D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008680:Metaraminol / Q000627:therapeutic use*; D010208:Papaverine / Q000627:therapeutic use*; D010410:Penile Erection / Q000187:drug effects*; D011317:Priapism / Q000188:drug therapy* / Q000209:etiology; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D014662:Vasoconstrictor Agents; D008680:Metaraminol; D010208:Papaverine
Les injections intracaverneuses de drogues dans les dysérections. Leur intérêt clinique à propos de 100 cas.